Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis.

Smart superparamagnetic iron oxide nanoparticles (SPIONs) are the most promising candidate for theragnosis (i.e., diagnosis and treatment) of multiple sclerosis. A deep understanding of the dynamics of the in vivo neuropathology of multiple sclerosis can be achieved by improving the efficiency of various medical techniques (e.g., positron emission tomography and magnetic resonance imaging) using multimodal SPIONs. In this Review, recent advances and challenges in the development of smart SPIONs for theragnostic applications are comprehensively described. In addition, critical outlines of emerging developments are provided from the points of view of both clinicians and nanotechnologists.

[1]  M. Mahmoudi,et al.  Superparamagnetic colloidal nanocrystal clusters coated with polyethylene glycol fumarate: a possible novel theranostic agent. , 2011, Nanoscale.

[2]  Morteza Mahmoudi,et al.  Irreversible changes in protein conformation due to interaction with superparamagnetic iron oxide nanoparticles. , 2011, Nanoscale.

[3]  M. Mahmoudi,et al.  Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. , 2011, Advanced drug delivery reviews.

[4]  Mohammad Ali Sahraian,et al.  Role of MRI in diagnosis and treatment of multiple sclerosis , 2010, Clinical Neurology and Neurosurgery.

[5]  Paul M Matthews,et al.  Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. , 2010, Brain : a journal of neurology.

[6]  Deli Jiang,et al.  MRI shows clodronate-liposomes attenuating liver injury in rats with severe acute pancreatitis. , 2010, Hepatobiliary & pancreatic diseases international : HBPD INT.

[7]  S. Laurent,et al.  Superparamagnetic Iron Oxide Nanoparticles , 2017 .

[8]  Joop A. Peters,et al.  Glycoconjugate probes and targets for molecular imaging using magnetic resonance. , 2010, Future medicinal chemistry.

[9]  Ludwig Kappos,et al.  A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. , 2010, The New England journal of medicine.

[10]  David C. Zhu,et al.  Magnetic glyco-nanoparticles: a tool to detect, differentiate, and unlock the glyco-codes of cancer via magnetic resonance imaging. , 2010, Journal of the American Chemical Society.

[11]  M. C. Stuart,et al.  Emerging applications of stimuli-responsive polymer materials. , 2010, Nature materials.

[12]  J. Fütterer,et al.  In vivo imaging of the aneurysm wall with MRI and a macrophage-specific contrast agent. , 2009, AJR. American journal of roentgenology.

[13]  P Stroeve,et al.  Cell toxicity of superparamagnetic iron oxide nanoparticles. , 2009, Journal of colloid and interface science.

[14]  M. Trojano,et al.  Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis , 2009, Biologics : targets & therapy.

[15]  S. Laurent,et al.  In Vivo Detection of Inflammation Using Pegylated Iron Oxide Particles Targeted at E-Selectin: A Multimodal Approach Using MR Imaging and EPR Spectroscopy , 2009, Investigative radiology.

[16]  Sungho Jin,et al.  Magnetic nanoparticles for theragnostics. , 2009, Advanced drug delivery reviews.

[17]  Clinton F Jones,et al.  In vitro assessments of nanomaterial toxicity. , 2009, Advanced drug delivery reviews.

[18]  M. Mahmoudi,et al.  Superparamagnetic Iron Oxide Nanoparticles with Rigid Cross-linked Polyethylene Glycol Fumarate Coating for Application in Imaging and Drug Delivery , 2009 .

[19]  P. Matthews,et al.  Pathway and network-based analysis of genome-wide association studies in multiple sclerosis , 2009, Human molecular genetics.

[20]  P. Matthews.  Brain imaging of multiple sclerosis: the next 10 years. , 2009, Neuroimaging clinics of North America.

[21]  E. Syková,et al.  Poly(N,N-dimethylacrylamide)-coated maghemite nanoparticles for stem cell labeling. , 2009, Bioconjugate chemistry.

[22]  Mehrdad Hamidi,et al.  Hydrogel nanoparticles in drug delivery. , 2008, Advanced drug delivery reviews.

[23]  N. Nighoghossian,et al.  Novel Applications of Magnetic Resonance Imaging to Image Tissue Inflammation after Stroke , 2008, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[24]  H. Karlsson,et al.  Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. , 2008, Chemical research in toxicology.

[25]  Zhenghe Xu,et al.  Asialoglycoprotein receptor-targeted superparamagnetic iron oxide nanoparticles. , 2008, International journal of pharmaceutics.

[26]  E. Warburton,et al.  Correlation of Carotid Atheromatous Plaque Inflammation Using USPIO-Enhanced MR Imaging With Degree of Luminal Stenosis , 2008, Stroke.

[27]  B. Trapp,et al.  Multiple sclerosis: an immune or neurodegenerative disorder? , 2008, Annual review of neuroscience.

[28]  C. Robic,et al.  Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.

[29]  Su Jin Kang,et al.  Titanium dioxide nanoparticles trigger p53‐mediated damage response in peripheral blood lymphocytes , 2008, Environmental and molecular mutagenesis.

[30]  Joseph A Frank,et al.  In Vitro Model of Bromodeoxyuridine or Iron Oxide Nanoparticle Uptake by Activated Macrophages from Labeled Stem Cells: Implications for Cellular Therapy , 2008, Stem cells.

[31]  V. Rotello,et al.  Protein-passivated Fe(3)O(4) nanoparticles: low toxicity and rapid heating for thermal therapy. , 2008, Journal of materials chemistry.

[32]  M. Gotoh,et al.  Sequential magnetic resonance imaging for evaluation of Kupffer cell function. , 2008, Hepato-gastroenterology.

[33]  Frederik Barkhof,et al.  Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. , 2008, Brain : a journal of neurology.

[34]  Yongxing Hu,et al.  Highly tunable superparamagnetic colloidal photonic crystals. , 2007, Angewandte Chemie.

[35]  J. Santamaría,et al.  Magnetic nanoparticles for drug delivery , 2007 .

[36]  Michael D Shultz,et al.  Reactive nature of dopamine as a surface functionalization agent in iron oxide nanoparticles. , 2007, Journal of the American Chemical Society.

[37]  Andreas Saleh,et al.  Imaging Inflammation in Acute Brain Ischemia , 2007, Stroke.

[38]  Christian Plank,et al.  Generation of magnetic nonviral gene transfer agents and magnetofection in vitro , 2007, Nature Protocols.

[39]  Philippe Robert,et al.  Recent advances in iron oxide nanocrystal technology for medical imaging. , 2006, Advanced drug delivery reviews.

[40]  Fiona Wood,et al.  Nanocrystalline silver dressings in wound management: a review , 2006, International journal of nanomedicine.

[41]  P. Tiberto,et al.  Magnetic properties of the ferrimagnetic glass-ceramics for hyperthermia , 2006 .

[42]  J. Rühe,et al.  Dynamically Reconfigurable Polymer Films: Impact on Nanomotion , 2006 .

[43]  Xavier Montet,et al.  Interaction of Functionalized Superparamagnetic Iron Oxide Nanoparticles with Brain Structures , 2006, Journal of Pharmacology and Experimental Therapeutics.

[44]  Robert L. Clark,et al.  Micro-cantilevers with end-grafted stimulus-responsive polymer brushes for actuation and sensing , 2006 .

[45]  Ludwig Kappos,et al.  A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. , 2006, The New England journal of medicine.

[46]  A. J. Nijdam,et al.  Nanotechnologies for biomolecular detection and medical diagnostics. , 2006, Current opinion in chemical biology.

[47]  F. Gazeau,et al.  Controlled clustering of superparamagnetic nanoparticles using block copolymers: design of new contrast agents for magnetic resonance imaging. , 2005, Journal of the American Chemical Society.

[48]  S. Laurent,et al.  Specific E-selectin targeting with a superparamagnetic MRI contrast agent. , 2006, Contrast media & molecular imaging.

[49]  Stephen R. Wilson,et al.  [60]fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. , 2005, Nano letters.

[50]  F. Lublin.  History of modern multiple sclerosis therapy , 2005, Journal of Neurology.

[51]  John M Pauly,et al.  Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles , 2005, Magnetic resonance in medicine.

[52]  Alastair Compston,et al.  McAlpine's Multiple Sclerosis , 2005 .

[53]  Rong Zhou,et al.  Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. , 2004, Academic radiology.

[54]  É. Duguet,et al.  Magnetic nanoparticle design for medical diagnosis and therapy , 2004 .

[55]  T. Xiaoping,et al.  Effects of La3+ doping on MnZn ferrite nanoscale particles synthesized by hydrothermal method , 2004 .

[56]  Nathan Kohler,et al.  A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. , 2004, Journal of the American Chemical Society.

[57]  S. Laurent,et al.  Control of the synthesis of magnetic fluids by relaxometry and magnetometry , 2004 .

[58]  Kazunori Kataoka,et al.  PEGylated Nanoparticles for Biological and Pharmaceutical Applications , 2003 .

[59]  D B Warheit,et al.  PULMONARY TOXICITY STUDIES IN RATS WITH TRIETHOXYOCTYLSILANE (OTES)-COATED, PIGMENT-GRADE TITANIUM DIOXIDE PARTICLES: BRIDGING STUDIES TO PREDICT INHALATION HAZARD , 2003, Experimental lung research.

[60]  H. Hartung,et al.  Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial , 2002, The Lancet.

[61]  U. Heinzmann,et al.  Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. , 2001, Environmental health perspectives.

[62]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[63]  A. Huczko,et al.  PHYSIOLOGICAL TESTING OF CARBON NANOTUBES: ARE THEY ASBESTOS-LIKE? , 2001 .

[64]  A. Huczko,et al.  CARBON NANOTUBES: EXPERIMENTAL EVIDENCE FOR A NULL RISK OF SKIN IRRITATION AND ALLERGY , 2001 .

[65]  J. Debatin,et al.  Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits , 2001, Circulation.

[66]  R Weissleder,et al.  Improvement of MRI probes to allow efficient detection of gene expression. , 2000, Bioconjugate chemistry.

[67]  Margaret Evans Best,et al.  High K/sub u/ materials approach to 100 Gbits/in/sup 2/ , 2000 .

[68]  E. Blums,et al.  Synthesis and properties of Mn-Zn ferrite ferrofluids , 1999 .

[69]  C. Bartolozzi,et al.  Abdominal MR: liver and pancreas , 1999, European Radiology.

[70]  R. Gurny,et al.  Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics. , 1998, Advanced drug delivery reviews.

[71]  W Semmler,et al.  Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in Vivo by using transferrin receptor pathways , 1998, Magnetic resonance in medicine.

[72]  C. Granger,et al.  Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis , 1996, Annals of neurology.

[73]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. , 1990, Radiology.

[74]  E. Pollert.  Crystal chemistry of magnetic oxides part 2: Hexagonal ferrites , 1985 .

[75]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[76]  Toyoichi Tanaka,et al.  Kinetics of swelling of gels , 1979 .

[77]  J. W. Brown.  Thermal Fluctuations of a Single-Domain Particle , 1963 .

[78]  E. Kabat,et al.  AN ELECTROPHORETIC STUDY OF THE PROTEIN COMPONENTS IN CEREBROSPINAL FLUID AND THEIR RELATIONSHIP TO THE SERUM PROTEINS. , 1942, The Journal of clinical investigation.